NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|496082004|ref|WP_008806511|]
View 

MULTISPECIES: NAD(P)H-dependent oxidoreductase [Klebsiella]

Protein Classification

NAD(P)H-dependent oxidoreductase( domain architecture ID 10495002)

NAD(P)H-dependent oxidoreductase which catalyzes the reduction or oxidation of a substrate coupled to the oxidation or reduction, respectively, of a nicotinamide adenine dinucleotide cofactor NAD(P)H or NAD(P)+

CATH:  3.40.50.360
EC:  1.-.-.-
Gene Ontology:  GO:0050136|GO:0008753|GO:0010181
SCOP:  3001217

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
2-188 1.23e-39

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


:

Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 133.61  E-value: 1.23e-39
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 496082004    2 SNILIINGAKKFAHSNGQLNDTLTEVaesyLRDAGHDVKSV-------------------RAESEYDVKAEVQNFLWADV 62
Cdd:pfam02525   1 MKILIINAHPRPGSFSSRLADALVEA----LKAAGHEVTVRdlyalflpvldaedladltYPQGAADVESEQEELLAADV 76
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 496082004   63 VIWQMPGWWMGAPWTVKKYMDDVFTEGHGSLYAsdgrtrsdasKKYGSGGLVQGKKYMLSLTWNAPMEAFTDEdqFFHGV 142
Cdd:pfam02525  77 IVFQFPLYWFSVPALLKGWIDRVLRAGFAFKYE----------EGGPGGGGLLGKKVLVIVTTGGPEYAYGKG--GYNGF 144
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*....
gi 496082004  143 GVDGVYLPFHKANQFLGMEALPTFIANDV---IKMPDVPRYIAEYRKHL 188
Cdd:pfam02525 145 SLDELLPYLRGILGFCGITDLPPFAVEGTagpEDEAALAEALERYEERL 193
 
Name Accession Description Interval E-value
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
2-188 1.23e-39

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 133.61  E-value: 1.23e-39
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 496082004    2 SNILIINGAKKFAHSNGQLNDTLTEVaesyLRDAGHDVKSV-------------------RAESEYDVKAEVQNFLWADV 62
Cdd:pfam02525   1 MKILIINAHPRPGSFSSRLADALVEA----LKAAGHEVTVRdlyalflpvldaedladltYPQGAADVESEQEELLAADV 76
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 496082004   63 VIWQMPGWWMGAPWTVKKYMDDVFTEGHGSLYAsdgrtrsdasKKYGSGGLVQGKKYMLSLTWNAPMEAFTDEdqFFHGV 142
Cdd:pfam02525  77 IVFQFPLYWFSVPALLKGWIDRVLRAGFAFKYE----------EGGPGGGGLLGKKVLVIVTTGGPEYAYGKG--GYNGF 144
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*....
gi 496082004  143 GVDGVYLPFHKANQFLGMEALPTFIANDV---IKMPDVPRYIAEYRKHL 188
Cdd:pfam02525 145 SLDELLPYLRGILGFCGITDLPPFAVEGTagpEDEAALAEALERYEERL 193
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
3-192 2.14e-22

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 89.13  E-value: 2.14e-22
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 496082004   3 NILIIngakkFAHSNGQ-LNDTLTEVAESYLRDAGHDVK-----------SVRAESEY-------DVKAEVQNFLWADVV 63
Cdd:COG2249    1 KILII-----YAHPDPSsFNAALAEAAAEGLEAAGHEVTvhdlyaegfdpVLSAADFYrdgplpiDVAAEQELLLWADHL 75
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 496082004  64 IWQMPGWWMGAPWTVKKYMDDVFTegHGSLYASDGRtrsdaskkyGSGGLVQGKKYMLSLTWNAPMEAFTD-------ED 136
Cdd:COG2249   76 VFQFPLWWYSMPALLKGWIDRVLT--PGFAYGYGGG---------YPGGLLKGKKALLVVTTGGPEEAYSRlgyggpiEE 144
                        170       180       190       200       210
                 ....*....|....*....|....*....|....*....|....*....|....*...
gi 496082004 137 QFFHGVgvdgvylpFHkanqFLGMEALPTFIANDVIKMPD--VPRYIAEYRKHLAEIF 192
Cdd:COG2249  145 LLFRGT--------LG----YCGMKVLPPFVLYGVDRSSDeeRAAWLERVRELLAALA 190
PRK00871 PRK00871
glutathione-regulated potassium-efflux system oxidoreductase KefF;
49-190 4.55e-05

glutathione-regulated potassium-efflux system oxidoreductase KefF;


Pssm-ID: 234852  Cd Length: 176  Bit Score: 42.08  E-value: 4.55e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 496082004  49 DVKAEVQNFLWADVVIWQMPGWWMGAPWTVKKYMDDVFTEGHGslyasdgrtrsdaskkYGSGGLVQGKKYMLsltWNAP 128
Cdd:PRK00871  45 DIAAEQEALSRADLIVWQHPMQWYSIPPLLKLWIDKVLSHGWA----------------YGHGGTALHGKHLL---WAVT 105
                         90       100       110       120       130       140       150
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 496082004 129 MEAftDEDQFFHGV--GVDGVYLPFHKANQFLGMEALP------TFIANDvikmPDVPRYIAEYRKHLAE 190
Cdd:PRK00871 106 TGG--GESHFEIGAhpGFDVLSQPLQATALYCGLNWLPpfamhcTFICDD----ETLEGQARHYKQRLLE 169
 
Name Accession Description Interval E-value
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
2-188 1.23e-39

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 133.61  E-value: 1.23e-39
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 496082004    2 SNILIINGAKKFAHSNGQLNDTLTEVaesyLRDAGHDVKSV-------------------RAESEYDVKAEVQNFLWADV 62
Cdd:pfam02525   1 MKILIINAHPRPGSFSSRLADALVEA----LKAAGHEVTVRdlyalflpvldaedladltYPQGAADVESEQEELLAADV 76
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 496082004   63 VIWQMPGWWMGAPWTVKKYMDDVFTEGHGSLYAsdgrtrsdasKKYGSGGLVQGKKYMLSLTWNAPMEAFTDEdqFFHGV 142
Cdd:pfam02525  77 IVFQFPLYWFSVPALLKGWIDRVLRAGFAFKYE----------EGGPGGGGLLGKKVLVIVTTGGPEYAYGKG--GYNGF 144
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*....
gi 496082004  143 GVDGVYLPFHKANQFLGMEALPTFIANDV---IKMPDVPRYIAEYRKHL 188
Cdd:pfam02525 145 SLDELLPYLRGILGFCGITDLPPFAVEGTagpEDEAALAEALERYEERL 193
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
3-192 2.14e-22

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 89.13  E-value: 2.14e-22
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 496082004   3 NILIIngakkFAHSNGQ-LNDTLTEVAESYLRDAGHDVK-----------SVRAESEY-------DVKAEVQNFLWADVV 63
Cdd:COG2249    1 KILII-----YAHPDPSsFNAALAEAAAEGLEAAGHEVTvhdlyaegfdpVLSAADFYrdgplpiDVAAEQELLLWADHL 75
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 496082004  64 IWQMPGWWMGAPWTVKKYMDDVFTegHGSLYASDGRtrsdaskkyGSGGLVQGKKYMLSLTWNAPMEAFTD-------ED 136
Cdd:COG2249   76 VFQFPLWWYSMPALLKGWIDRVLT--PGFAYGYGGG---------YPGGLLKGKKALLVVTTGGPEEAYSRlgyggpiEE 144
                        170       180       190       200       210
                 ....*....|....*....|....*....|....*....|....*....|....*...
gi 496082004 137 QFFHGVgvdgvylpFHkanqFLGMEALPTFIANDVIKMPD--VPRYIAEYRKHLAEIF 192
Cdd:COG2249  145 LLFRGT--------LG----YCGMKVLPPFVLYGVDRSSDeeRAAWLERVRELLAALA 190
PRK00871 PRK00871
glutathione-regulated potassium-efflux system oxidoreductase KefF;
49-190 4.55e-05

glutathione-regulated potassium-efflux system oxidoreductase KefF;


Pssm-ID: 234852  Cd Length: 176  Bit Score: 42.08  E-value: 4.55e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 496082004  49 DVKAEVQNFLWADVVIWQMPGWWMGAPWTVKKYMDDVFTEGHGslyasdgrtrsdaskkYGSGGLVQGKKYMLsltWNAP 128
Cdd:PRK00871  45 DIAAEQEALSRADLIVWQHPMQWYSIPPLLKLWIDKVLSHGWA----------------YGHGGTALHGKHLL---WAVT 105
                         90       100       110       120       130       140       150
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 496082004 129 MEAftDEDQFFHGV--GVDGVYLPFHKANQFLGMEALP------TFIANDvikmPDVPRYIAEYRKHLAE 190
Cdd:PRK00871 106 TGG--GESHFEIGAhpGFDVLSQPLQATALYCGLNWLPpfamhcTFICDD----ETLEGQARHYKQRLLE 169
WrbA COG0655
Multimeric flavodoxin WrbA, includes NAD(P)H:quinone oxidoreductase [Energy production and ...
3-83 3.22e-04

Multimeric flavodoxin WrbA, includes NAD(P)H:quinone oxidoreductase [Energy production and conversion];


Pssm-ID: 440420 [Multi-domain]  Cd Length: 181  Bit Score: 39.53  E-value: 3.22e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 496082004   3 NILIINGAKKfAHSNgqlNDTLTEVAESYLRDAGHDVKSVRAeSEYDVK------------------AEVQNFLWADVVI 64
Cdd:COG0655    1 KILVINGSPR-KNGN---TAALAEAVAEGAEEAGAEVELIRL-ADLDIKpcigcggtgkcvikddmnAIYEKLLEADGII 75
                         90
                 ....*....|....*....
gi 496082004  65 WQMPGWWMGAPWTVKKYMD 83
Cdd:COG0655   76 FGSPTYFGNMSAQLKAFID 94
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH